Marjorie S. Read - Concepedia

Author

Marjorie S. Read

University of North Carolina at Chapel Hill

Also Known As

BRINKHOUS, K., Evatt, Bruce, M Read, M S Read, M. Read, M. S. Read, M.S Read, M.S. Read, MARJORIE S. READ, Marjorie Read

Publications

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill East Carolina University Baylor College of Medicine

About

Marjorie S. Read is an author at University of North Carolina at Chapel Hill specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	29	2.9K
2	Health Sciences	6	6	495
3	Engineering	2	2	152
4	Education	1	1	72
5	Public Health	1	1	60

Marjorie S. Read

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Roland W. Herzog, Edmund Y. Yang, Linda B. Couto, Nature Medicine PathogenesisHematologyImmunologyVeterinary SciencePathology	1999	562
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors Richard O. Snyder, Carol H. Miao, Leonard Meuse, Nature Medicine Molecular VirologyViral PathogenesisImmunologyVeterinary ScienceHematology	1999	407
In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs Mark A. Kay, Steven Rothenberg, Charles N. Landen, Science HistocompatibilityGeneticsImmunologyPathologyVivo Gene Therapy	1993	306
Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. K. M. Brinkhous, H Sandberg, Joel B. Garris, Proceedings of the National Academy of Sciences ThrombosisIsolated F.viiiMedicineHematologyImmunology	1985	174
Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in Liver Lili Wang, Timothy C. Nichols, Marjorie S. Read, Molecular Therapy	2000	174
Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Marjorie S. Read, R W Shermer, K. M. Brinkhous Proceedings of the National Academy of Sciences Normal PlasmasImmunologyPlatelet Aggregation DependentImmunotherapyThrombosis	1978	157
Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression B Fang, Randy C. Eisensmith, H. Wang, Human Gene Therapy	1995	127
Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Marjorie S. Read, Robert L. Reddick, Arthur P. Bode, Proceedings of the National Academy of Sciences EngineeringImmunologyDried PlateletsBiomedical EngineeringInflammation	1995	119
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Bingliang Fang, Heming Wang, Gerald W. Gordon, PubMed	1996	108
The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion Jay N. Lozier, Amalia Dutra, Evgenia Pak, Proceedings of the National Academy of Sciences Chapel HillCytogeneticsGeneticsPathogenesisHematology	2002	101

Page 1